193 related articles for article (PubMed ID: 37232462)
1. The Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease.
Çelik K; Güveli H; Erzin Y; Kenge EB; Özlü T
Turk J Gastroenterol; 2023 Jul; 34(7):714-719. PubMed ID: 37232462
[TBL] [Abstract][Full Text] [Related]
2. Adherence to mediterranean diet in patients with inflammatory bowel disease.
Fiorindi C; Dinu M; Gavazzi E; Scaringi S; Ficari F; Nannoni A; Sofi F; Giudici F
Clin Nutr ESPEN; 2021 Dec; 46():416-423. PubMed ID: 34857229
[TBL] [Abstract][Full Text] [Related]
3. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease.
Vrdoljak J; Vilović M; Živković PM; Tadin Hadjina I; Rušić D; Bukić J; Borovac JA; Božić J
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33171662
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Mediterranean Diet's Adherence in children with Inflammatory Bowel Diseases.
Strisciuglio C; Cenni S; Serra MR; Dolce P; Martinelli M; Staiano A; Miele E
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092159
[TBL] [Abstract][Full Text] [Related]
5. Adherence to Mediterranean diet in Crohn's disease.
Papada E; Amerikanou C; Forbes A; Kaliora AC
Eur J Nutr; 2020 Apr; 59(3):1115-1121. PubMed ID: 31006053
[TBL] [Abstract][Full Text] [Related]
6. Beliefs About Medicines and Adherence to Treatment in Turkish Patients with Inflammatory Bowel Disease.
Can G; Yozgat A; Tezel A; Ünsal G; Soylu AR
Turk J Gastroenterol; 2022 Sep; 33(9):743-750. PubMed ID: 35946875
[TBL] [Abstract][Full Text] [Related]
7. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
8. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies.
Khalili H; Håkansson N; Chan SS; Chen Y; Lochhead P; Ludvigsson JF; Chan AT; Hart AR; Olén O; Wolk A
Gut; 2020 Sep; 69(9):1637-1644. PubMed ID: 31900290
[TBL] [Abstract][Full Text] [Related]
9. The association between inflammatory potential of diet and disease activity: results from a cross-sectional study in patients with inflammatory bowel disease.
Lamers CR; de Roos NM; Witteman BJM
BMC Gastroenterol; 2020 Sep; 20(1):316. PubMed ID: 32993520
[TBL] [Abstract][Full Text] [Related]
10. Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies.
Reznikov EA; Suskind DL
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771373
[TBL] [Abstract][Full Text] [Related]
11. Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review.
Roncoroni L; Gori R; Elli L; Tontini GE; Doneda L; Norsa L; Cuomo M; Lombardo V; Scricciolo A; Caprioli F; Costantino A; Scaramella L; Vecchi M
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215401
[TBL] [Abstract][Full Text] [Related]
12. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.
Erdoğan Ç; Yeşil B; Bacaksız F; Arı D; Gökbulut V; Yüksel M; Özderin Özin Y; Kayaçetin E
Turk J Gastroenterol; 2022 Oct; 33(10):831-837. PubMed ID: 35946879
[TBL] [Abstract][Full Text] [Related]
13. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.
Guthrie E; Jackson J; Shaffer J; Thompson D; Tomenson B; Creed F
Am J Gastroenterol; 2002 Aug; 97(8):1994-9. PubMed ID: 12190166
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of factors that trigger inflammatory bowel disease flares.
Feagins LA; Iqbal R; Spechler SJ
World J Gastroenterol; 2014 Apr; 20(15):4329-34. PubMed ID: 24764669
[TBL] [Abstract][Full Text] [Related]
15. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
17. Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.
Erol Doğan Ö; Karaca Çelik KE; Baş M; Alan EH; Çağın YF
Nutrients; 2024 May; 16(10):. PubMed ID: 38794742
[TBL] [Abstract][Full Text] [Related]
18. Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease.
Pastore RL; Wolff BG; Hodge D
Dis Colon Rectum; 1997 Dec; 40(12):1455-64. PubMed ID: 9407985
[TBL] [Abstract][Full Text] [Related]
19. Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
Shamseya AM; Hussein WM; Elnely DA; Adel F; Header DA
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e803-e809. PubMed ID: 34678857
[TBL] [Abstract][Full Text] [Related]
20. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
